BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221205
DTEND;VALUE=DATE:20221209
DTSTAMP:20260516T042853
CREATED:20220819T112000Z
LAST-MODIFIED:20220819T112000Z
UID:34927-1670198400-1670543999@www.pharmajournalist.com
SUMMARY:4th Annual Gene Therapy for Neurological Disorders
DESCRIPTION:Delivering the Next Wave of Gene Therapies to the CNS \nWith systemic toxicity challenges plaguing the AAV field\, direct administration for CNS indications creates an ideal target for gene therapy. This is an exciting year for the neurological space with clinical data to show and new biotechs coming out of the woodwork to release the next wave of gene therapies with more advanced CNS targeting for a wider selection of neurological targets. \nThe 4th Annual Gene Therapy for Neurological Disorders Summit will unite gene therapy developers with an industry-focused agenda across 4 days and 2 dedicated tracks of content to solve the preclinical\, translational and clinical challenges of targeting a wide range of neurodevelopmental and neurodegenerative disorders with both ‘first’ and ‘next’ generation gene therapies. \nJoin the expanding audience of gene therapy experts to: \n\nStreamline CNS drug delivery devices for improved brain biodistribution\nDiscover novel vectors for CNS specificity & tropism\nOptimize gene therapy strategy for pediatric & adult neurological disorders\n\nTo know more visit: https://ter.li/rluqrj
URL:https://www.pharmajournalist.com/event/4th-annual-gene-therapy-for-neurological-disorders/
LOCATION:The Westin Seaport District\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221205
DTEND;VALUE=DATE:20221208
DTSTAMP:20260516T042853
CREATED:20220919T115535Z
LAST-MODIFIED:20220919T115535Z
UID:35224-1670198400-1670457599@www.pharmajournalist.com
SUMMARY:4th Annual Cell Therapy Analytical Development Summit
DESCRIPTION:Cell Therapy Analytical Development Summit US is back for its fourth year\, taking place in Boston (December 5-7). Join 180+ colleagues from analytical development\, process development\, quality control and regulatory affairs\, to standardize analytical testing and take advantage of unrivalled content across: \n\n3-days\n6 deep-dive workshops\n2 tracks\n\nSeize an unmatched opportunity to delve into cell potency\, safety\, viability\, sterility and more across both autologous and allogeneic cell therapy products. \nPlease use this URL – https://ter.li/ghwxjk
URL:https://www.pharmajournalist.com/event/4th-annual-cell-therapy-analytical-development-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
END:VEVENT
END:VCALENDAR